Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-acting Levodopa for OSA in Parkinson's Disease
NCT03111485Phase 4Completed
- Sponsor
- McGill University Health Centre
- Start
- May 2017
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levodopa + carbidopa in obstructive sleep apnea (OSA), sponsored by McGill University Health Centre. Started May 2017; status: completed.
02
Drugs
levodopa + carbidopa
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT03111485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03111485.